Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133+ and CD34+ hematopoietic stem and progenitor cells.

Bissels U, Wild S, Tomiuk S, Hafner M, Scheel H, Mihailovic A, Choi YH, Tuschl T, Bosio A.

Stem Cells. 2011 May;29(5):847-57. doi: 10.1002/stem.627.

2.

Megakaryocytic differentiation of CD133+ hematopoietic stem cells by down-regulation of microRNA-10a.

Zarif MN, Soleimani M, Abolghasemi H, Amirizade N, Arefian E, Rahimian A.

Hematology. 2013 Mar;18(2):93-100. doi: 10.1179/1607845412Y.0000000047. Epub 2012 Nov 19.

PMID:
23321646
3.

Integrated analysis of miRNA and mRNA expression in childhood medulloblastoma compared with neural stem cells.

Genovesi LA, Carter KW, Gottardo NG, Giles KM, Dallas PB.

PLoS One. 2011;6(9):e23935. doi: 10.1371/journal.pone.0023935. Epub 2011 Sep 9.

4.

MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line.

Nam EJ, Lee M, Yim GW, Kim JH, Kim S, Kim SW, Kim YT.

BMC Med Genomics. 2012 May 29;5:18. doi: 10.1186/1755-8794-5-18.

5.

Expression of genes regulating angiogenesis in human circulating hematopoietic cord blood CD34+/CD133+ cells.

Pomyje J, Zivný J, Sefc L, Plasilová M, Pytlík R, Necas E.

Eur J Haematol. 2003 Mar;70(3):143-50.

PMID:
12605658
6.

Human fetal hepatic progenitor cells are distinct from, but closely related to, hematopoietic stem/progenitor cells.

Chen Q, Khoury M, Limmon G, Choolani M, Chan JK, Chen J.

Stem Cells. 2013 Jun;31(6):1160-9. doi: 10.1002/stem.1359.

7.

microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.

Zhang J, Luo N, Luo Y, Peng Z, Zhang T, Li S.

Int J Oncol. 2012 Mar;40(3):747-56. doi: 10.3892/ijo.2011.1242. Epub 2011 Oct 24.

PMID:
22025269
8.

CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants.

Radtke S, Görgens A, Kordelas L, Schmidt M, Kimmig KR, Köninger A, Horn PA, Giebel B.

Br J Haematol. 2015 Jun;169(6):868-78. doi: 10.1111/bjh.13362. Epub 2015 Mar 29.

PMID:
25819405
9.

Gene and miRNA expression profiles of hematopoietic progenitor cells vary depending on their origin.

Báez A, Martín-Antonio B, Piruat JI, Barbado MV, Prats C, Álvarez-Laderas I, Carmona M, Pérez-Simón JA, Urbano-Ispizua Á.

Biol Blood Marrow Transplant. 2014 May;20(5):630-9. doi: 10.1016/j.bbmt.2014.01.022. Epub 2014 Jan 23.

10.

Biology and plasticity of CD133+ hematopoietic stem cells.

Handgretinger R, Gordon PR, Leimig T, Chen X, Buhring HJ, Niethammer D, Kuci S.

Ann N Y Acad Sci. 2003 May;996:141-51.

PMID:
12799292
11.

Insulin-like growth factor binding proteins-2 and -4 enhance the migration of human CD34-/CD133+ hematopoietic stem and progenitor cells.

Bartling B, Koch A, Simm A, Scheubel R, Silber RE, Santos AN.

Int J Mol Med. 2010 Jan;25(1):89-96.

PMID:
19956906
12.

CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control.

Georgantas RW 3rd, Hildreth R, Morisot S, Alder J, Liu CG, Heimfeld S, Calin GA, Croce CM, Civin CI.

Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2750-5. Epub 2007 Feb 9.

13.

Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3.

Guo R, Wu Q, Liu F, Wang Y.

Oncol Rep. 2011 Jan;25(1):141-6.

PMID:
21109969
14.

CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin.

Bühring HJ, Kuçi S, Conze T, Rathke G, Bartolović K, Grünebach F, Scherl-Mostageer M, Brümmendorf TH, Schweifer N, Lammers R.

Stem Cells. 2004;22(3):334-43.

15.

miRNA expression profile of colon cancer stem cells compared to non-stem cells using the SW1116 cell line.

Fang Y, Xiang J, Chen Z, Gu X, Li Z, Tang F, Zhou Z.

Oncol Rep. 2012 Dec;28(6):2115-24. doi: 10.3892/or.2012.2054. Epub 2012 Sep 24.

PMID:
23007737
16.

A miRNA Signature in Human Cord Blood Stem and Progenitor Cells as Potential Biomarker of Specific Acute Myeloid Leukemia Subtypes.

Cattaneo M, Pelosi E, Castelli G, Cerio AM, D'Angiò A, Porretti L, Rebulla P, Pavesi L, Russo G, Giordano A, Turri J, Cicconi L, Lo-Coco F, Testa U, Biunno I.

J Cell Physiol. 2015 Aug;230(8):1770-80. doi: 10.1002/jcp.24876.

PMID:
25502508
17.
18.

CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells.

Takahashi M, Matsuoka Y, Sumide K, Nakatsuka R, Fujioka T, Kohno H, Sasaki Y, Matsui K, Asano H, Kaneko K, Sonoda Y.

Leukemia. 2014 Jun;28(6):1308-15. doi: 10.1038/leu.2013.326. Epub 2013 Nov 5.

19.

Micro-RNA30c negatively regulates REDD1 expression in human hematopoietic and osteoblast cells after gamma-irradiation.

Li XH, Ha CT, Fu D, Xiao M.

PLoS One. 2012;7(11):e48700. doi: 10.1371/journal.pone.0048700. Epub 2012 Nov 7.

20.

MicroRNA expression profiles in umbilical cord blood cell lineages.

Merkerova M, Vasikova A, Belickova M, Bruchova H.

Stem Cells Dev. 2010 Jan;19(1):17-26. doi: 10.1089/scd.2009.0071.

PMID:
19435428

Supplemental Content

Support Center